Synergy CHC Corp. (SNYR)
NASDAQ: SNYR · Real-Time Price · USD
2.350
+0.010 (0.43%)
Sep 5, 2025, 11:11 AM - Market open
Synergy CHC Revenue
Synergy CHC had revenue of $8.13M in the quarter ending June 30, 2025, with 1.37% growth. This brings the company's revenue in the last twelve months to $33.70M, down -18.71% year-over-year. In the year 2024, Synergy CHC had annual revenue of $34.83M, down -18.57%.
Revenue (ttm)
$33.70M
Revenue Growth
-18.71%
P/S Ratio
0.57
Revenue / Employee
$1,604,908
Employees
21
Market Cap
26.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.83M | -7.94M | -18.57% |
Dec 31, 2023 | 42.78M | 4.37M | 11.37% |
Dec 31, 2022 | 38.41M | -1.82M | -4.51% |
Dec 31, 2020 | 40.23M | 10.87M | 37.02% |
Dec 31, 2019 | 29.36M | -4.47M | -13.21% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SNYR News
- 8 days ago - Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering - GlobeNewsWire
- 10 days ago - Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering - GlobeNewsWire
- 22 days ago - Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability - GlobeNewsWire
- 3 months ago - Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Help Drive FOCUSfactor Energy Drink Global Expansion - GlobeNewsWire
- 3 months ago - Synergy CHC Announces New $20 Million Long-Term Credit Facility - GlobeNewsWire
- 4 months ago - Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information - GlobeNewsWire
- 11 months ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
- 11 months ago - Synergy CHC Corp. Announces Closing of Initial Public Offering - GlobeNewsWire